Lyondell Reports First Quarter 2002 Results
Highlights - Demand improves but rising feedstock costs offset benefits. - Milestone reached with Occidental in transactions to acquire Equistar stake. - Lyondell's cash balance increases $82 million to $228 million. HOUSTON, April 25 /PRNewswire-FirstCall/ -- For the first quarter 2002, Lyondell Chemical Company (NYSE: LYO) reported a net loss of $55 million, or $0.47 per share. This compares with a loss of $53 million, or $0.46 per share, for the fourth quarter 2001, and a loss of $34 million, or $0.29 per share, for the first quarter of 2001. EBITDA (earnings before net interest, taxes, depreciation and amortization) for Lyondell and the proportionate share of its joint ventures was $139 million in the first quarter 2002. This compares with EBITDA, excluding unusual and extraordinary items, of $136 million in the fourth quarter 2001 and $174 million in the first quarter 2001. Lyondell's estimated effective tax rate for 2002 is 25 percent, compared to the federal statutory rate of 35 percent. This difference increased Lyondell's reported net loss in the first quarter 2002 by $7 million, or $0.06 per share. Compared to the fourth quarter 2001, the first quarter benefited from higher sales volumes in many of Lyondell's businesses, completion of scheduled maintenance in the refining business and seasonal improvement in the MTBE business. However, rapidly escalating raw material costs in the second half of the quarter more than offset the improvements, particularly in the petrochemicals and polymers businesses. "The chemical industry and Lyondell continued to operate in trough conditions during the quarter," said Dan F. Smith, Lyondell's President and Chief Executive Officer. "While we were encouraged to see improved demand for many of our products, these gains were overwhelmed by continuing volatility in raw materials markets. Despite this difficult environment, Lyondell's cash balance increased $82 million during the quarter, including a $97 million tax refund. "We also made further progress in improving our efficiency and cost position. As previously announced, we consolidated the business management, marketing and sales functions for Lyondell and Equistar under a single chief operating officer, further implementing the organization's shared services model. "Additionally, we have completed certain key steps toward implementing our previously announced agreement in principle to purchase Occidental's 29.5 percent interest in Equistar, and to sell an equity interest in Lyondell to Occidental." On April 19, the formal "right of first offer" process commenced in connection with a portion of the Occidental transactions. Under this process, Millennium Chemicals, the third partner in Equistar, has 45 days to decide whether to participate on a pro-rata basis in the acquisition of Occidental's Equistar interest. At the end of the process, Occidental, Lyondell and, if it elects to participate, Millennium are expected to sign definitive documentation. Closing of the transactions will be subject to certain conditions, including approval by Lyondell's shareholders. OUTLOOK "In the second quarter of 2002, we are seeing modest demand improvement for many of our products and seasonal improvement in our fuels businesses. In addition, we are implementing price increases in some product areas," Smith said. "This should result in improved financial performance, barring large upward movement in raw material costs. " Lyondell Earnings Summary (A) Millions of dollars except per share amounts 1Q2002 4Q2001 1Q2001 Net Income (Loss) Before Unusual and Extraordinary Items (B) (C) $(55) $(58) $(28) Earnings (Loss) per Share Before Unusual and Extraordinary Items (B) (C) $(0.47) $(0.50) $(0.24) Net Income (Loss) As Reported $(55) $(53) $(34) Earnings (Loss) per Share As Reported $(0.47) $(0.46) $(0.29) EBITDA (Lyondell and proportionate share of ventures) (B) (C) $139 $136 $174 (A) See Consolidated Income Statements. (B) The fourth quarter 2001 excludes a $10 million after-tax benefit from reduction of the third quarter 2001 ADI (aliphatic diisocyanates) shutdown charge and an after-tax extraordinary charge of $5 million related to early debt retirement. (C) The first quarter 2001 excludes an after-tax charge of $6 million, consisting of Lyondell's share of Equistar's facility shutdown costs. IMPLEMENTATION OF FASB STATEMENT NO. 142 As a result of the implementation of FASB Statement No. 142 on accounting for goodwill and other intangible assets, Equistar wrote off its $1.1 billion of goodwill in the first quarter 2002. This write-off had no effect on Lyondell's financials, including the carrying value of Lyondell's investment in Equistar. The implementation of FASB Statement No. 142 for Lyondell results in the elimination of $30 million of annual amortization, but did not affect Lyondell's carrying value of goodwill. INTERMEDIATE CHEMICALS & DERIVATIVES (IC&D) The IC&D segment includes propylene oxide (PO) and derivatives, styrene monomer and MTBE. Excluding unusual and extraordinary items in prior quarters, EBITDA for the first quarter 2002 was $95 million, compared to $90 million in the fourth quarter 2001 and $97 million in the first quarter of 2001. Higher margins for the gasoline additive MTBE contributed to the increased EBITDA in the first quarter 2002, as did greater PO and derivatives sales volumes, compared to the fourth quarter of 2001. PO and derivatives volumes increased six percent largely due to demand in the polyurethane end market. However, the benefits were offset by a decline in styrene margins. Lyondell's MTBE sales volumes also declined versus the fourth quarter 2001. EQUISTAR CHEMICALS, LP Equistar's EBITDA, excluding unusual items and the cumulative effect of accounting changes, was a negative $1 million in the first quarter 2002, compared to $39 million in the fourth quarter 2001 and $69 million in the first quarter 2001. Equistar's Petrochemicals segment had EBITDA of $29 million in the first quarter 2002, compared to $101 million in the fourth quarter 2001 and $166 million in the first quarter of 2001. Compared to the fourth quarter 2001, sales volumes for petrochemicals increased 6.5 percent in the first quarter 2002 due to improved demand in the first quarter 2002 following aggressive industry inventory reductions that characterized the fourth quarter 2001. However, the benefits of increased demand were offset by a significant reduction in ethylene margins. During the first quarter 2002, ethylene prices declined in an environment of rising feedstock and energy costs. In addition, certain fixed-price natural gas and natural gas liquids (NGL) supply contracts, which were entered into in early 2001, resulted in costs that were approximately $33 million higher than market-based contracts would have been for the same period. Most of these contracts expired at the end of the first quarter 2002. Equistar's Polymers segment had EBITDA of negative $6 million in the first quarter 2002, compared to a negative $32 million in the fourth quarter 2001 and a negative $75 million in the first quarter of 2001. Compared to the fourth quarter of 2001, the Polymers segment benefited from improved margins, as falling ethylene prices more than offset lower polyethylene prices. The Polymers segment also benefited from volume improvements of three percent in the quarter. LYONDELL-CITGO REFINING LP (LCR) LCR had EBITDA of $78 million in the first quarter 2002, compared to EBITDA of $54 million in the fourth quarter 2001 and $86 million in the first quarter of 2001. Processed crude volumes increased as the refinery returned to routine operations following a major turnaround in the fourth quarter of 2001. In the first quarter 2002, LCR processed 261,000 barrels a day, of which 229,000 barrels a day were Venezuelan crude supplied under the crude supply agreement (CSA). In the fourth quarter 2001, LCR processed 207,000 barrels a day, of which 196,000 barrels a day were CSA volumes. While LCR's operational reliability during the first quarter 2002 was very good, operating rates were reduced due to poor spot margins early in the quarter. As a result, total crude processing rates in the quarter were reduced. Petroleos de Venezuela S.A. (PDVSA), the national oil company of Venezuela, curtailed CSA crude deliveries to 198,000 barrels a day in March 2002 under declaration of force majeure. However, the curtailment was largely offset by CSA inventories built during the scheduled turnaround in the fourth quarter 2001. Sales Revenues Millions of dollars 1Q2002 4Q2001 1Q2001 Reported Sales Revenues $674 $709 $849 Total sales revenues - all businesses in which Lyondell participates (A) $2,543 $2,510 $3,577 Lyondell's proportionate share of the sales revenues of businesses in which it participates (A) $1,575 $1,561 $2,143 (A) Includes revenues from sales to affiliates. Lyondell Chemical Company, (www.lyondell.com ), headquartered in Houston, Texas, is the world's largest producer of propylene oxide (PO); the world's number three supplier of TDI (toluene diisocyanate); a leading producer of propylene glycol; a leading producer of other PO derivatives such as BDO (butanediol) and PGE (propylene glycol ether); and a producer of styrene monomer and MTBE as co-products of PO production. Through its 41% interest in Equistar Chemicals, LP, Lyondell also is one of the largest producers of ethylene, propylene and polyethylene in North America and a leading producer of polypropylene, ethylene oxide, ethylene glycol, high value-added specialty polymers and polymeric powder. Through its 58.75% interest in LYONDELL-CITGO Refining LP, Lyondell is one of the largest refiners in the United States, processing extra heavy Venezuelan crude oil to produce gasoline, low sulfur diesel and jet fuel. Lyondell is the third largest methanol producer in the U.S., through its 75% interest in Lyondell Methanol Company, L.P. The statements in this release relating to matters that are not historical facts are forward-looking statements that are subject to risks and uncertainties. Actual results could differ materially, based on factors including, but not limited to, future global economic conditions, further increases in raw material and/or energy costs, access to capital markets, industry production capacity and operating rates, the supply/demand balance for Lyondell's and its joint ventures' products, competitive products and pricing pressures, technological developments, changes in governmental regulations and other risk factors. For more detailed information about the factors that could cause actual results to differ materially, please refer to Lyondell's Annual Report on Form 10-K for the year ended December 31, 2001, filed with the Securities and Exchange Commission in March 2002, Lyondell's Quarterly Report on Form 10-Q for the quarter ended March 31, 2002, which will be filed in May 2002, and the proxy statement that Lyondell will file with the Securities and Exchange Commission with respect to its Special Meeting of Shareholders relating to the transactions with Occidental. LYONDELL CHEMICAL COMPANY SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED) (Millions of dollars) Lyondell Lyondell Chemical and Company Proportionate (Excluding Joint Ventures Share of Equity Equistar LCR LMC Equity Investments) Investments (A) 100% 100% 100% (B) Three months ended March 31, 2002: Sales and other operating revenues (C) $674 $1,136 $707 $26 $1,575 SG&A and R&D 47 49 12 2 76 EBITDA before cumulative effect of accounting change 95 (1) 78 (2) 139 Depreciation and amortization 60 (D) 75 (F) 29 2 106 Net interest expense 91 (D) 52 (F) 8 --- 117 Capital expenditures 11 (E) 15 22 --- 30 Dividends 26 26 Three months ended December 31, 2001: Sales and other operating revenues (C) $709 $1,185 $592 $24 $1,561 SG&A and R&D 48 60 17 2 84 EBITDA before unusual and extraordinary charges 90 39 54 (3) 136 Depreciation and amortization 70 (D) 82 (F) 27 3 119 Net interest expense 92 (D) 52 (F) 10 --- 119 Capital expenditures 16 (E) 25 50 --- 56 Dividends 27 27 Three months ended March 31, 2001: Sales and other operating revenues (C) $849 $1,773 $910 $45 2,143 SG&A and R&D 49 56 14 1 81 EBITDA before unusual charges 97 69 86 (2) 174 Depreciation and amortization 65 (D) 78 28 3 113 Net interest expense 92 (D) 46 16 --- 120 Capital expenditures 11 24 11 --- 27 Dividends 27 27 (A) Consists of the operations of the Intermediate Chemicals and Derivatives business segment. (B) This column reflects Lyondell's 100% owned operations and its pro rata share of each joint venture's operations and is not a presentation in accordance with generally accepted accounting principles. Lyondell owns a 41% interest in Equistar Chemicals, LP ("Equistar"), a 58.75% interest in LYONDELL-CITGO Refining LP ("LCR") and a 75% interest in Lyondell Methanol Company ("LMC"). (C) Includes revenues from sales to affiliates. (D) "Depreciation and amortization" and "net interest expense" both include approximately $4 million of noncash amortization of debt issuance costs in each of the three-month periods ended March 31, 2002 and December 31, 2001 and $3 million for March 31, 2001. Goodwill amortization ceased effective January 1, 2002. (E) Excludes contributions to PO-11 joint venture and U.S. PO joint venture of $13 million, $45 million and $15 million in the three- month periods ended March 31, 2002, December 31, 2001 and March 31, 2001, respectively. (F) "Depreciation and amortization" and "net interest expense" both include approximately $2 million and $1 million of noncash amortization of debt issuance costs in each of the three-month periods ended March 31, 2002 and December 31, 2001, respectively. Goodwill amortization ceased effective January 1, 2002. LYONDELL CHEMICAL COMPANY SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED) For the three months INCOME STATEMENTS March 31, (Millions of dollars, except per share data) 2002 2001 Sales and other operating revenues $674 $849 Operating costs and expenses: Cost of sales 589 761 Selling, general and administrative expenses 40 41 Research and development 7 8 Amortization of goodwill --- 8 Operating income 38 31 Loss from equity investment in Equistar (A) (45) (22) Income from equity investment in LCR 27 27 Loss from other equity investments (3) (3) Interest expense, net (91) (92) Other income (expense), net 1 3 Loss before income taxes (73) (56) Benefit from income taxes (18) (22) Net loss (A) $(55) $(34) Basic and diluted earnings per share: Net loss (A) $(0.47) $(0.29) Weighted average shares outstanding (in thousands) 117,565 117,562 INTERMEDIATE CHEMICALS AND DERIVATIVES SEGMENT SELECTED FINANCIAL AND OPERATING INFORMATION (Millions of dollars) Sales and other operating revenues $674 $849 Operating income 38 31 EBITDA 95 97 Sales Volumes (millions) PO and derivatives (pounds) (B) 785 722 Co-products: Styrene monomer (pounds) 786 789 TBA and derivatives (gallons) 267 245 (A) Lyondell's 41% share of Equistar's $1.1 billion charge for the write-off of goodwill, or $432 million, was offset by a credit resulting from Lyondell's write-off of the difference between its investment in Equistar and its 41% share of Equistar's partners' capital. (B) Includes propylene oxide ("PO"), PO derivatives and isocyanates. LYONDELL CHEMICAL COMPANY SELECTED FINANCIAL INFORMATION (UNAUDITED) (Millions of dollars) For the three months ended March 31, 2002 2001 STATEMENTS OF CASH FLOWS Net loss $(55) $(34) Adjustments to reconcile net loss to net cash provided (used) by operating activities: Depreciation and amortization 60 65 Losses from equity investments 48 22 Accounts receivable 28 68 Inventories 13 (92) Accounts payable (42) (17) Changes in other working capital and other, net 118 (57) Net cash provided (used) by operating activities 170 (45) Expenditures for property, plant and equipment (11) (11) Contributions and advances to affiliates (A) (38) (20) Distributions from affiliates in excess of earnings --- 11 Net cash used in investing activities (49) (20) Repayments of long-term debt (13) (2) Dividends paid (26) (27) Other --- (3) Net cash used in financing activities (39) (32) Effect of exchange rate changes on cash --- (1) Increase (decrease) in cash and cash equivalents $82 $(98) (A) Includes contributions to PO-11 joint venture and U.S. PO joint venture of $13 million and $15 million in the three-month periods ended March 31, 2002 and 2001, respectively. LYONDELL CHEMICAL COMPANY SELECTED FINANCIAL INFORMATION (UNAUDITED) (Millions of dollars) March 31, December 31, 2002 2001 BALANCE SHEET Cash and cash equivalents $228 $146 Accounts receivable, net 320 352 Inventories 303 316 Prepaid expenses and other current assets 45 116 Deferred tax assets 61 277 Total current assets 957 1,207 Property, plant and equipment, net 2,265 2,293 Investments and long-term receivables: Investment in PO joint ventures 722 717 Investment in Equistar 477 522 Receivable from LCR 229 229 Investment in LCR 54 29 Investment in LMC 35 36 Other investments and long-term receivables 83 86 Goodwill, net 1,100 1,102 Other assets 453 482 Total assets $6,375 $6,703 Accounts payable $275 $319 Current maturities of long-term debt 7 7 Other accrued liabilities 282 233 Total current liabilities 564 559 Long-term debt 3,833 3,846 Other liabilities 589 583 Deferred income taxes 580 790 Minority interest 155 176 Stockholders' equity (117,564,920 and 117,562,920 shares outstanding respectively at March 31, 2002 and December 31, 2001) 654 749 Total liabilities and stockholders' equity $6,375 $6,703 Investment in Equistar, January 1, 2002 $522 Lyondell's share of Equistar net loss (45) Investment in Equistar, March 31, 2002 $477 Investment in LCR, January 1, 2002 $29 Lyondell's share of LCR net income 27 Cash distributions from LCR (24) Cash contributions to LCR 22 Investment in LCR, March 31, 2002 $54 Investment in LMC, January 1, 2002 $36 Lyondell's share of LMC net loss (3) Cash contributions to LMC 3 Other (1) Investment in LMC, March 31, 2002 $35 LYONDELL CHEMICAL COMPANY EQUISTAR CHEMICALS, LP SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED) For the three months ended March 31, 2002 2001 INCOME STATEMENTS (Millions of dollars) Sales and other operating revenues (A) $1,136 $1,773 Operating costs and expenses: Cost of sales 1,162 1,723 Selling, general and administrative expenses 40 46 Research and development 9 10 Amortization of goodwill --- 8 Unusual charges --- 22 Operating loss (75) (36) Interest expense, net (52) (46) Other income, net 1 5 Loss before cumulative effect of accounting change (126) (77) Cumulative effect of accounting change (B) (1,053) --- Net loss (C) $(1,179) $(77) SELECTED FINANCIAL AND OPERATING INFORMATION (Millions of dollars) Sales and other operating revenues (A) Petrochemicals segment $993 $1,689 Polymers segment 410 542 Intersegment eliminations (267) (458) Total $1,136 $1,773 Other operating expenses (D) Petrochemicals segment $2 $6 Polymers segment 17 18 Unallocated 30 32 Total $49 $56 Operating income (loss) Petrochemicals segment $(24) $115 Polymers segment (21) (89) Unallocated (30) (62) Total $(75) $(36) EBITDA before accounting change Petrochemicals segment $29 $166 Polymers segment (6) (75) Unallocated (24) (44) Total $(1) $47 EBITDA before accounting change and unusual charges $(1) $69 Sales Volumes (A) Selected petrochemical products (millions): Ethylene, propylene and other olefins (pounds) 4,137 4,241 Aromatics (gallons) 86 90 Polymers products (millions of pounds) 1,508 1,441 (A) Includes revenues/volumes from sales to affiliates. (B) Concurrent with the adoption of FASB Statement No. 142, Goodwill and Other Intangible Assets, Equistar reviewed goodwill for impairment and concluded that the entire balance was impaired, resulting in the $1.1 billion charge. (C) As a partnership, Equistar is not subject to federal income taxes. (D) Other operating expenses include SG&A and R&D. LYONDELL CHEMICAL COMPANY EQUISTAR CHEMICALS, LP SELECTED FINANCIAL INFORMATION (UNAUDITED) (Millions of dollars) March 31, December 31, 2002 2001 BALANCE SHEETS Cash and cash equivalents $15 $202 Accounts receivable, net 580 540 Inventories 421 448 Prepaid expenses and other current assets 31 36 Total current assets 1,047 1,226 Property, plant and equipment, net 3,660 3,705 Goodwill, net --- 1,053 Other assets 341 324 Total assets $5,048 $6,308 Accounts payable $412 $360 Current maturities of long-term debt 4 104 Other accrued liabilities 111 197 Total current liabilities 527 661 Long-term debt 2,282 2,233 Other liabilities 181 177 Partners' capital 2,058 3,237 Total liabilities and partners' capital $5,048 $6,308 For the three months ended March 31, 2002 2001 SELECTED CASH FLOW INFORMATION Depreciation and amortization $75 $78 Cash flow from operations (119) (154) Capital expenditures 15 24 LYONDELL CHEMICAL COMPANY LYONDELL-CITGO REFINING LP SELECTED FINANCIAL AND OPERATING INFORMATION (UNAUDITED) March 31, December 31, 2002 2001 CONDENSED BALANCE SHEETS (Millions of dollars) Total current assets $258 $230 Property, plant and equipment, net 1,338 1,343 Deferred charges and other assets 97 97 Total assets $1,693 $1,670 Notes payable $16 $50 Current maturities of long-term debt 450 --- Other current liabilities 374 335 Long-term debt --- 450 Loans payable to partners 264 264 Other liabilities and deferred credits 80 79 Partners' capital 509 492 Total liabilities and partners' capital $1,693 $1,670 For the three months ended March 31, 2002 2001 INCOME STATEMENTS (Millions of dollars) Sales and other operating revenues (A) $707 $910 Operating costs and expenses: Cost of sales 646 838 Selling, general and administrative expenses 12 14 Operating income 49 58 Interest expense, net (8) (16) Net income (B) $41 $42 SELECTED CASH FLOW INFORMATION (Millions of dollars) Depreciation and amortization $29 $28 Cash flow from operations 61 37 Capital expenditures 22 11 EBITDA $78 $86 SELECTED OPERATING INFORMATION Sales Volumes (including intersegment sales) (A) Refined products (thousand barrels per day): Gasoline 105 106 Diesel and heating oil 80 71 Jet fuel 22 20 Aromatics 8 10 Other refinery products 115 104 Total refined products volumes 330 311 Refinery Runs Crude processing rates (thousand barrels per day): Crude Supply Agreement - coked 229 231 Other heavy crude oil - coked 6 23 Other crude oil 26 5 Total crude oil 261 259 (A) Includes revenues/volumes from sales to affiliates. (B) As a partnership, LCR is not subject to federal income taxes. MAKE YOUR OPINION COUNT - Click Here http://tbutton.prnewswire.com/prn/11690X36207610 SOURCE Lyondell Chemical Company |